COGT vs MTB · $5.75B cap vs P/E 12, rev $860.0M
Cogent Biosciences Inc (COGT) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Cogent Biosciences Inc (COGT) is a biotechnology company listed on NASDAQ.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
COGT does not have a complete income-statement cache yet.
Latest reported MTB revenue for 2026-06-30 was $860.0M. Net income was $1.48B. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
COGT currently screens at market cap $5.75B. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the COGT and MTB stock pages for the full models.
Not investment advice.